AlphaCentric Advisors’s Apellis Pharmaceuticals APLS Stock Holding History

AlphaCentric Advisors’s Portfolio APLS Stock Details APLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell
2024 Q3	$1.37M	Buy
2021 Q3	–	Sell
2021 Q2	$126K	Hold
2021 Q1	$86K	Hold
2020 Q4	$114K	Buy
2020 Q3	$12K	Buy